US BANCORP \DE\ - PMV PHARMACEUTICALS INC ownership

PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 112 filers reported holding PMV PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PMV PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,765
-66.7%
370
-39.3%
0.00%
Q4 2022$5,307
-59.2%
610
-42.1%
0.00%
Q3 2022$13,000
+225.0%
1,053
+259.4%
0.00%
Q2 2022$4,000
-90.5%
293
-85.5%
0.00%
Q1 2022$42,000
+2000.0%
2,016
+2588.0%
0.00%
Q4 2021$2,000750.00%
Other shareholders
PMV PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Euclidean Capital LLC 2,336,909$48,654,00028.27%
INTERWEST VENTURE MANAGEMENT CO 3,234,911$67,351,00025.73%
OUP Management Co., LLC 989,232$20,596,00015.68%
Nextech Invest Ltd. 1,385,807$28,853,0008.24%
Boxer Capital, LLC 3,498,636$72,842,0003.74%
COWEN AND COMPANY, LLC 1,261,529$26,265,0002.53%
Orbimed Advisors 6,855,423$142,730,0002.31%
RTW INVESTMENTS, LP 3,872,154$80,618,0001.67%
PERSONAL CFO SOLUTIONS, LLC 350,342$7,294,0001.44%
ACUTA CAPITAL PARTNERS, LLC 135,500$2,821,0001.32%
View complete list of PMV PHARMACEUTICALS INC shareholders